Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience

Bibliographic Details
Main Authors:	Rossi M, Gonzales S, Orsoni J, Zavota L, De Fanti A, Izzi GC
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

<it>Staphylococcus aureus </it>and autoimmune uveitis reactivation in childhood: a possible correlation?
by: Zavota Laura, et al.
Published: (2009-11-01)

Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice
by: Ercan Calıskan, et al.
Published: (2021-10-01)

Parma in Lombard Emilia Parma nell'Emilia longobarda
by: Claudio Azzara
Published: (2004-06-01)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
by: Henry Alistair I, et al.
Published: (2011-11-01)

The Bourgeois Goes to Parma
by: Mariolina Bongiovanni Bertini
Published: (2018-07-01)

Etanercept
by: Sibel Alper
Published: (2022-04-01)

The Symbol and the Reason. Numbers, Shape and Measure in the Architecture of Parma’s Cemetery
by: Michela Rossi
Published: (2015-07-01)

Parma nell'Emilia longobarda
by: Claudio Azzara
Published: (2004-06-01)

Viktor Parma - raziskovalna izhodišča
by: Darja Frelih
Published: (1993-12-01)

Social Housing: the case of Parma
by: Sonia Peron
Published: (2012-10-01)

Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis
by: Tarek K. Motawi, et al.
Published: (2019-01-01)

Etanercept-Induced Anti-Glomerular Basement Membrane Disease
by: Saif Al-Chalabi, et al.
Published: (2021-09-01)

A review of ocular adverse events of biological anti-TNF drugs
by: Fernanda Nicolela Susanna, et al.
Published: (2020-04-01)

Neuronal NMDAR Currents of the Hippocampus and Learning Performance in Autoimmune Anti-NMDAR Encephalitis and Involvement of TNF-α and IL-6
by: Xu Wang, et al.
Published: (2019-06-01)

Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood
by: Nishide M, et al.
Published: (2022-03-01)

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model.
by: Nithidol Sakunrangsit, et al.
Published: (2021-01-01)

Analysis of the bark beetle outbreak in the forest “Alta Val Parma” (Corniglio, Parma, Italy) and strategies for its regeneration
by: Vignali G, et al.
Published: (2015-12-01)

Ocular surface and salivary gland involvement in patients with autoimmune thyroid disease
by: Flavia Pelinsari Lana, et al.
Published: (2015-02-01)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
by: Uta Kiltz, et al.
Published: (2022-08-01)

Association of TNF-alpha polymorphism (-308 A/G) with high activity of rheumatoid arthritis and therapy response to etanercept
by: Marinković Milena, et al.
Published: (2011-01-01)

The surgical treatment of BRONJ: Parma Maxillofacial Surgery School experience
by: Sesenna E, et al.
Published: (2010-05-01)

Etanercept in axial spondyloarthritis
by: Gui Luo, et al.
Published: (2022-11-01)

ETANERCEPT WITHDRAWAL IN JIA
by: Oana-Maria Farkas, et al.
Published: (2017-06-01)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
by: Loris Riccardo Lopetuso, et al.
Published: (2023-05-01)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
by: Anna Felis-Giemza, et al.
Published: (2019-10-01)

The Possible Community: a project for the CSAC of Parma.
by: Lamberto Amistadi
Published: (2019-01-01)

Correction to: Parma consensus statement on metabolic disruptors
by: Jerrold J. Heindel, et al.
Published: (2017-12-01)

The Early Bronze Age site of Eia (Parma)
by: Tania Quero
Published: (2014-12-01)

Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013-03-01)

Behçet's Disease and Etanercept: Eighty Weeks of Experience
by: B. Kroegler, et al.
Published: (2009-05-01)

The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages
by: Elnaz Shirmohammadi, et al.
Published: (2020-09-01)

Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders
by: S Oertle, et al.
Published: (2002-07-01)

Proactive monitoring of anti-TNF agents improves follow-up of paediatric patients with Crohn disease
by: Begoña Rodríguez Azor, et al.
Published: (2023-03-01)

Psoriasis, lymphoma and etanercept: is there a correlation? Psoríase, linfoma e etanercepte: existe correlação?
by: Ludmilla Queirós Miranda, et al.
Published: (2012-02-01)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017-07-01)

ESPERIENZE NELLA GESTIONE DI EPIDEMIE NOSOCOMIALI: POLICLINICO UNIVERSITARIO DI PARMA
by: M.G. Menozzi, et al.
Published: (2004-06-01)

Etanercept for the treatment of rheumatoid arthritis.
by: Lethaby, A, et al.
Published: (2013)

Etanercept for the treatment of rheumatoid arthritis.
by: Blumenauer, B, et al.
Published: (2003)

Etanercept for the treatment of rheumatoid arthritis
by: Blumenauer, B, et al.
Published: (2004)

Etanercept (review of international studies)
by: D E Karateev
Published: (2009-10-01)